Cialis
Cialis Erectile Dysfunction
Home Bookmark this Site

News » Jan 2004

Cialis doesn't boost Icos stock
January 6, 2004

BOTHELL -- Some investors expected to see the price of ICOS Corp.'s stock increase once the company's erectile dysfunction drug received federal approval in November.

Instead, the biotechnology firm's share price has dropped 12 percent since Cialis' approval, including a 6 percent drop on Monday alone.

Company officials have said there's no particular news that should cause the stock to drop.

In the months before Cialis won approval from the U.S. Food and Drug Administration, ICOS' stock increased in anticipation. That helped the stock price rise more than 75 percent during 2003.

Paul Latta, an analyst with McAdams Wright Ragen Inc. in Seattle, said several factors are responsible for the recent drop. He attributed Monday's relatively large fall for ICOS' stock price, from $40.88 to $38.35 a share, to profit-taking as the new tax year began.

"My theory is ... a lot of people wanted to take some gains, but if they did it before today, they would have had to take those gains in the prior tax year, when many people already had a lot of gains," Latta said.

Add to that a downbeat conference call by Eli Lilly & Co., the pharmaceutical giant who's partnered with ICOS on Cialis. In that call, Lilly executives said the company's earnings in 2004 won't meet Wall Street's prior expectations, and that it could be 2006 before its joint venture with ICOS becomes profitable.

"That ought not to be a reason for selling the stock, because that ought not to be new news to investors," Latta said. Still, it may have had an effect.

He said a preliminary number of prescriptions written for Cialis last week also showed a decline from the previous week's totals. While the holiday-shortened week would explain that, it was cited as a possible drag on the stock.

He added that some investors also are nervous that ICOS and Lilly haven't launched their expensive blitz of TV commercials and other advertisements for Cialis, even as the drug's rivals, Viagra and Levitra, have been advertising heavily. ICOS spokeswoman Lacy Fitzpatrick said last week that ads should begin this quarter.

ICOS is the largest publicly traded company with headquarters in Snohomish County, with a market capitalization of $2.4 billion as of Monday.

source:-http://heraldnet.com

More Information:

Canadian Pharmacies | Canada Drugs - Canadian Pharmacies - save up to 70% on prescription and medications drugs from our online canada pharmacy!

Online Canadian Pharmacy - CanadaDrugsOnline.com is the leading industry of online pharmacy It deals with perception drugs by mail and any other way.

MedSpecial.com - Discount prescriptions. Viagra, Phentermine, Cialis, Levitra and lots more. Free overnight delivery.

News Archive
Year 2005
» October
» August
» July
» June
» May
» April
» March
» February
» January
Year 2004
» December
» November
» October
» September
» August
» July
» June
» May
» April
» March
» Febraury
» January
Year 2003
» November
» October
» September
» August
» July
» Buy Cialis

 

 

Cialis | Erectile Dysfunction | Mens Health Articles | Glossary
© 2006 cpotent.com All Right Reserved
Cialis is a registered trademark of Lilly ICOS LLC. All other trademarks are the property of their respective owners.